The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be highly effective […]

By Dennis Thompson HealthDay Reporter THURSDAY, Nov. 5, 2020 (HealthDay News) America’s ongoing opioid epidemic is costing increasing numbers of addicts their eyesight, a new study reports. The number of drug addicts who developed vision-endangering eye infections quadrupled between 2003 and 2016, according to researchers. “For whatever reason, these infections […]

FRIDAY, Nov. 6, 2020 (HealthDay News) If you use an oxygen concentrator and a pulse oximeter at home, proper use is crucial, the U.S. Food and Drug Administration says. Conditions such as asthma, lung cancer, chronic obstructive pulmonary disease, the flu and COVID-19 can all cause oxygen levels in the […]

By Ernie Mundell and Robin Foster HealthDay Reporters An experimental nasal spray against the new coronavirus is effective in animals, researchers report. The spray completely protected ferrets from the virus, according to the new study. The international team of scientists said the spray is nontoxic and stable and, if effective […]

FRIDAY, Nov. 6, 2020 (HealthDay News) A new study suggests that COVID-19 doesn’t infect the eye’s cornea. Although viruses such as herpes simplex can infect the cornea and Zika has been found in corneal tissue and tears, this does not appear to be the case with COVID-19, according to researchers […]

Breaking News

Recent Posts